Gene therapy edges towards commercial reality
        
            By Reuters, 
                Reuters
             | 05. 25. 2009
        
                    
                                    
                    
                                                                                                                                    
                                                                            
                              
    
  
  
    
  
          
  
      
    
            LONDON, (Reuters) - Gene therapy may be about to become a commercial reality, 20 years after the first experiments with the ground-breaking medical technology.
But the tale of two biotech companies - one British and one U.S. - suggests a tricky road ahead.
On the one side, French authorities recently allowed an experimental gene medicine from Britain's Ark Therapeutics to be prescribed to certain patients with brain cancer, even though it is not approved for general use.
The news boosted hopes that the European Medicines Agency will clear Ark's drug Cerepro for sale across the European Union in the second half of 2009.
By contrast, U.S.-based Introgen Therapeutics - which had been competing to get the first gene therapy approved in Western markets - filed for bankruptcy in December, after a regulatory setback for its experimental cancer drug Advexin.
The last two decades have seen more than 1,470 clinical trials involving gene therapy, two-thirds of them aimed at cancer, according to the Journal of Gene Medicine.
But the only drug to get to market so far has been one for...
 
       
 
  
 
    
    
  
   
                        
                                                                                
                 
                                                    
                            
                                  
    
  
  
      Related Articles
    
  
          
  
  
  
  
  
  
      
            
                  
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Megan Molteni and Anil Oza,  STAT | 10.07.2025
                                                        
     
    
    
            For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Abby McCloskey,  The Dallas Morning News | 10.10.2025
                                                        
     
    
    
            We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Julia Black,  MIT Technology Review | 10.16.2025
                                                        
     
    
    
            Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Kaitlin Sullivan,  NBC News | 10.15.2025
                                                        
     
    
    
            
Two months after she was born, Eliana Nachem got a cough that wouldn’t go away. Three weeks later, she also started having runny stool, prompting a visit to her pediatrician. 
Eliana didn’t have allergies or a gastrointestinal condition; instead, tests...